The Pro Bono Wire

March 2006   VOLUME 1 ISSUE 9  
Charting the Future of Pro Bono Seminar Recap
Pfizer’s Jeffrey B. Kindler Honored for Exemplary Pro Bono Work
Microsoft and Seattle Law Firms Win 2006 CPBO Pro Bono Partner Award
Next Year’s Seminar to be Held March 1–3, 2007 at the Willard InterContinental
AppealTech Pro Bono Points Program Makes Pro Bono Easy
The Legal Services Corporation Board Provisions Committee Considers Ways to Promote Pro Bono
Pfizer’s Jeffrey B. Kindler Honored for Exemplary Pro Bono Work
Washington, DC * March 3, 2006

Contact:  Esther F. Lardent (202) 662-9231

Jeffrey B. Kindler of Pfizer Inc has been awarded the 2006 Laurie D. Zelon Pro Bono Award by the Pro Bono Institute at Georgetown University Law Center.  The award was be presented on March 3 as part of the 2006 Pro Bono Seminar/Forum on In-House Corporate Pro Bono in Washington, D.C.


In recognizing Kindler, the Pro Bono Institute cites his efforts to increase access to justice, expand pro bono legal assistance and promote diversity while serving as Pfizer’s vice chairman, general counsel and chief compliance officer.  


“We are pleased to recognize the outstanding contribution of Jeff Kindler and his long-standing commitment to ensuring that America’s corporate lawyers make pro bono work a priority,” said Esther F. Lardent, president of the Institute. “As a result of his efforts, thousands of people have gotten legal help who simply couldn’t afford it, and the principles Jeff has put in place at Pfizer will be a model for Corporate America for many years to come.”


“I’m honored to accept this award on behalf of all my Pfizer colleagues who believe so strongly in giving back to the community,” said Mr. Kindler.  “We will continue to do everything in our power to ensure that people who need legal representation - - particularly the poor and the disadvantaged - - get the kind of help they need when they need it.”


Under Mr. Kindler's leadership, Pfizer’s pro bono initiatives include providing traditional legal services to the underserved and creating a seminar series on “Strategic Legal Thinking for Not-for-Profit Executives.” The Legal Division has also developed new programs such as the New York Pro Bono Adoption Project, a coalition of law firm and Pfizer attorneys that provides services to adoptive parents in the foster care system.


Other accomplishments under Mr. Kindler’s leadership include:


Pfizer’s lawyers have provided assistance to the families of victims of the September 11 tragedy, aid to legal service organizations assisting victims of hurricanes Katrina and Rita and support to numerous community-based non-profit groups. 


Pfizer’s Legal Division has taken a proactive and broad-based approach to diversity.  Mr. Kindler has encouraged partnerships with diversity-related professional associations and organizations.  He has personally emphasized the importance of diversity to Pfizer's outside law firms and has made it a component of how the Division chooses outside counsel. 


In his role as member of the Advisory Board of Corporate Pro Bono, Mr. Kindler has championed the effort to develop the Corporate Pro Bono ChallengeSM, the first aspirational pro bono goal and benchmark for in-house legal departments.  The Pfizer Legal Division is a Charter Signatory to the Corporate Pro Bono Challenge and is actively involved in promoting the adoption of the Challenge by other corporate legal departments. 


“At Pfizer, respect for people is one of our core values, and we consider ‘a culture of inclusion’ to be one of our key strengths,” said Mr. Kindler.


The Laurie D. Zelon Award, named in honor of one of the founders of the Pro Bono Institute’s Law Firm Pro Bono Project, is presented each year to an individual or organization that has provided exemplary pro bono service. 


Mr. Kindler joined Pfizer in January 2002 from McDonald's Corporation in Chicago, where he was president of Partner Brands, as well as executive vice president, corporate relations, and general counsel.  He leads Pfizer groups devoted to legal affairs, corporate and regulatory compliance, corporate communications, government relations, philanthropy, policy development and analysis, corporate citizenship, global security, and information resources.


About Pro Bono Institute at Georgetown University Law Center (PBI)

Established in 1996, PBI is a non-profit organization mandated to explore and identify new approaches to the poor and disadvantaged unable to secure legal assistance to address critical problems.  In doing so, the Institute identifies and develops innovative programs and undertakes rigorous evaluations to ensure that these new approaches are workable and effective.   The Institute administers a number of projects designed to enhance access to justice, including:  the Law Firm Pro Bono Project, the Corporate Pro Bono Project, and the Reinventing Pro Bono Project for public interest organizations.


About Pfizer Inc

Pfizer Inc discovers prescription medicines that improve the quality of life for patients around the world and help them enjoy longer, healthier and more productive lives. Pfizer medicines are available in more than 180 countries and the company employs more than 106,000 colleagues worldwide.  The company is a global leader in philanthropy and community support, with a range of innovative programs that help low-income and disadvantaged patients get access to the medicines they need, as well as innovative partnerships attacking disease in the developing world.  More information about Pfizer can be found at

Powered by IMN